We are thrilled to have you on our site. If you enjoy the post you have just found kindly Share it with friends.
According to numerous reports, the United States is in talks with Moderna to purchase doses of the COVID-19 vaccine from a pharmaceutical company for distribution to low-income countries.
Discussions were the first CNBC reports Wednesday with a link to a friend. The discussions could lead to a similar deal announced earlier Wednesday with Pfizer, news outlets reported.
Moderna spokesman said Bloomberg News that the company is interested in possibly providing additional doses for other countries, but did not provide any further details on the discussions.
The Hill reached out to Moderna and the White House for comment.
The news of the talks came after several news outlets reported that the US was planning to purchase 500 million additional doses of Pfizer-BioNTech vaccine for international distribution.
President BidenJoe BidenHouse Judiciary Democrats call on Justice Department to overturn decision to defend Trump Democratic superpackage hunts Yangkin for voting rights Harris calls first overseas trip a success amid criticism from overseas MORE is expected to announce the deal at the G-7 summit in the UK this week.
White House National Security Advisor Jake SullivanJake SullivanBiden’s Favorite Ireland Is An Obstacle To Tax Deal Overnight Defense: Supreme Court Refuses to Consider Men-Only Draft Lawsuit | Drone powers a Navy fighter for the first time | NATO head meets Austin Biden Biden invites the President of Ukraine to the White House MORE refused to discuss details of the Pfizer-BioNTech deal on Wednesday, but said Biden will discuss steps the US is taking to transfer vaccine doses overseas on Thursday.
The White House has come under pressure to donate excess doses of vaccine to other countries that do not have the same access to vaccines as richer countries.
The administration has already announced that it will make 80 million doses of the vaccine available worldwide by the end of June. Last week it unveiled plans for distributing the first 25 million doses through the World Health Organization COVAX Center and other countries of the choice of the United States.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of Algulf.net and Algulf.net does not assume any responsibility or liability for the same.